Skip to main content
. 2012 Mar;10(1):2–13. doi: 10.1089/lrb.2011.0024

Table 2.

Overview of Genetic Analyses and Results for the 10 Candidate Genes Hypothesized to Influence Risk of Secondary Lymphedema Following Breast Cancer Treatment

Gene Gene regiona Sizeb(kilobases) # tagSNPs to cover HapMap SNPs in gene regionc # tagSNPs testedd Trend test p<0.05 (# of tagSNPs) Genotype-specific ORe>2.0 or <0.5 (# of tagSNPs) Mendelian patternfof ‘extreme’ ORs (# tagSNPs)
VEGFC chr4:177718895.177599691 119.2 kb 17 tagSNPs to capture 126 SNPs 17 0 5 4
VEGFR2 chr4:55939427.55996762 57.3 kb 29 tagSNPs to capture 55 SNPs 24 1 12 11
VEGFR3 chr5:180023507.180081624 58.1 kb 33 tagSNPs to capture 52 SNPs 32 3 14 13
RORC chr1:151773548.151809348 35.8 kb 23 tagSNPs to capture 39 SNPs 22 1 9 8
VEGFD chrX:15358718.15407577 48.9 kb 7 tagSNPs to capture 36 SNPs 7 0 4 2
PROX1 chr1:214156860.214214761 57.9 kb 13 tagSNPs to capture 35 SNPs 11 0 5 2
LYVE1 chr11:10574413.10595365 20.9kb 11 tagSNPs to capture 25 SNPs 8 0 4 3
ADM chr11:10321642.10333924 12.3 kb 8 tagSNPs to capture 11 SNPs 7 0 1 1
SOX18 chr20:62674081.62685979 11.9 kb 3 tagSNPs to capture 3 SNPs 3+ 3SNPsd 0 3 0
FOXC2 chr16:86595857.86607536 11.7 kb 2 tagSNPs to capture 2 SNPs 2 0 0 0
a

Co-ordinates from NCBI37 assembly; bAn extra 5 kb on each end of the genetic locus was included for TagSNP selection; cAs determined by Haploview version 4.2 using HapMap data release 24/phaseII, November 2008, on NCBI B36 assembly, dbSNP 126; dDifferences in # tagSNPs from # SNPs tested are due to failures in design or genotyping (16 of 152 total SNPs attempted). Additional SNPs were chosen to capture genetic variation in the SOX18 gene more completely; eOdds ratio (OR) reveals at least a doubling or halving of lymphedema risk for women who are heterozygous and/or homozygous for the rare allele; fPattern of odds ratios across the three genotypes conforms with co-dominant, dominant, or recessive mode of inheritance.